Biohaven (BHVN) Share-based Compensation (2021 - 2026)

Biohaven has disclosed Share-based Compensation across 6 years of filings, most recently posting $28.3 million for Q1 2026.

• Share-based Compensation for Q1 2026 came in at $28.3 million, down 46.69% year-over-year; the trailing twelve-month figure through Mar 2026 was $70.6 million (down 51.65% YoY), and the FY2024 annual result was $72.0 million, changed N/A from the prior year.
• Share-based Compensation came in at $28.3 million for Q1 2026 at Biohaven, up from $21.5 million in the prior quarter.
• In the past five years, Share-based Compensation ranged from a high of $101.4 million in Q4 2022 to a low of $1.8 million in Q1 2022.
• The 5-year median for Share-based Compensation is $20.8 million (2025), against an average of $29.3 million.
• Across the five-year window, Share-based Compensation surged 682.23% in 2022 and tumbled 73.78% in 2023, its largest moves.
• Biohaven's Share-based Compensation stood at $101.4 million in 2022, then tumbled by 95.61% to $4.5 million in 2023, then surged by 1440.01% to $68.6 million in 2024, then plunged by 68.62% to $21.5 million in 2025, then surged by 31.35% to $28.3 million in 2026.
• The last three Share-based Compensation figures came in at $28.3 million (Q1 2026), $21.5 million (Q3 2025), and $20.8 million (Q2 2025), per Business Quant data.